首页>
外国专利>
Alpha-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders
Alpha-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders
展开▼
机译:基质金属蛋白酶的α-磺酰氨基异羟肟酸抑制剂,用于治疗周围或中枢神经系统疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method of using a compound of the formula (I): CHEM wherein A, X1, X2, and Q are as defined herein, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof, in the treatment of a disease, condition or disorder of the peripheral or central nervous system, including but not limited to Alzheimer's disease, stroke/cerebral ischemia, head trauma, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, migraine, cerebral amyloid angiopathy, AIDS, age-related cognitive decline, mild cognitive impairment and prion diseases.
展开▼